Full-Exon Pyrosequencing Screening of BRCA Germline Mutations in Mexican Women with Inherited Breast and Ovarian Cancer

Hereditary breast cancer: clinical features and risk reduction strategies

(2011) A. Paradiso et al.   ANNALS OF ONCOLOGY

Accuracy and quality assessment of 454 GS-FLX Titanium pyrosequencing

(2011) André Gilles et al.   BMC GENOMICS

Two new CHEK2 germ-line variants detected in breast cancer/sarcoma families negative for BRCA1, BRCA2, and TP53 gene mutations

(2011) Siranoush Manoukian et al.   BREAST CANCER RESEARCH AND TREATMENT

Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)

(2011) Julie Lecarpentier et al.   BREAST CANCER RESEARCH AND TREATMENT

Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility

(2011) Mikko Vuorela et al.   BREAST CANCER RESEARCH AND TREATMENT

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling

(2011) Grace Wang et al.   GENETICS IN MEDICINE

Massive parallel amplicon sequencing of the breast cancer genes BRCA1 and BRCA2: opportunities, challenges, and limitations

(2011) Kim De Leeneer et al.   HUMAN MUTATION

Clinical Management of Hereditary Breast Cancer Syndromes

(2011) Amy S. Clark et al.   JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA

Hereditary breast and ovarian cancer due to mutations in BRCA1 and BRCA2

(2010) Nancie Petrucelli et al.   GENETICS IN MEDICINE

Characterization ofBRCA1andBRCA2deleterious mutations and variants of unknown clinical significance in unilateral and bilateral breast cancer: the WECARE study

(2010) Åke Borg et al.   HUMAN MUTATION

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

(2010) Andrew Tutt et al.   LANCET

Identification and Management of Women With BRCA Mutations or Hereditary Predisposition for Breast and Ovarian Cancer

(2010) Sandhya Pruthi et al.   MAYO CLINIC PROCEEDINGS

Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene

(2010) Alfons Meindl et al.   NATURE GENETICS

Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers

(2009) Roger L. Milne et al.   BREAST CANCER RESEARCH AND TREATMENT

Genomic rearrangements in BRCA1 and BRCA2: a literature review

(2009) Ingrid Petroni Ewald et al.   GENETICS AND MOLECULAR BIOLOGY

Preventing Future Cancers by Testing Women With Ovarian Cancer forBRCAMutations

(2009) Janice S. Kwon et al.   JOURNAL OF CLINICAL ONCOLOGY

A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing

(2009) Liying Zhang et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Genotyping of Frequent BRCA1/2 SNPs with Unlabeled Probes

(2009) Kim De Leeneer et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Pathogenicity of the BRCA1 missense variant M1775K is determined by the disruption of the BRCT phosphopeptide-binding pocket: a multi-modal approach

(2008) Marc Tischkowitz et al.   EUROPEAN JOURNAL OF HUMAN GENETICS